EverHint – Dip Bounce V2 (Reclaim) – Top 10 Signals for Oct 29, 2026
Excerpt: 10 signals (from 57 total). Healthcare leads (24). price range $11-$436. 2 with insider selling.
What This Signal Is
Production-ready dip-bounce strategy using reclaim pattern with Phase 2 market regime filters. Improved win rate from 40.42% (V1) to 50.18% (V2) with VIX and record high filters.
Entry Criteria:
- Minimum dip: 3.3% (open to intraday low)
- Minimum bounce: 1.0% from low
- Net change range: -2.0% to +0.3%
- Price above SMA(200)
- Minimum ADV: $40M
Holding period: 1-5 days | Risk level: Medium
Market Context
Markets are showing modest broad-based weakness on October 29, 2026, with the Nasdaq underperforming significantly at -1.38% compared to the Dow's milder -0.25% decline, suggesting tech-heavy growth names are bearing the brunt of selling pressure. This divergence points to a selective risk-off tone rather than a wholesale market retreat, which can actually create favorable conditions for dip-bounce strategies — particularly in sectors that have held up relatively well. The VIX reading of 17.20, up nearly 1.72% on the day, reflects modestly elevated uncertainty but remains well within a manageable range, meaning intraday swings are present but not extreme enough to invalidate technical reclaim setups.
For dip-bounce reclaim signals, the current volatility environment is constructive. A VIX in the mid-to-upper teens typically generates enough intraday price movement to trigger meaningful bounces off support levels without the erratic, whipsaw action seen during high-fear regimes above 25. The mild overall index decline suggests dip-buyers remain engaged, and the reclaim component of the strategy benefits from markets that are pulling back into structure rather than breaking down aggressively.
Healthcare's emergence as the top sector generating signals aligns well with the day's defensive rotation narrative. When growth and tech face headwinds, capital tends to migrate toward defensive sectors like healthcare, which can sustain relative strength and cleaner technical patterns even during broader market softness. This sector rotation dynamic improves the quality of dip-bounce reclaim setups in healthcare, as underlying demand support from institutional repositioning can provide the fuel needed to confirm price reclaims above key intraday levels.
📊 Signals (10 of 57 total)
Ranked by dip magnitude (highest first)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | ABSI | Absci Corporation | Healthcare | $12.10 | 0.35 | — | $2.1B |
| 2 | CTOS | Custom Truck One Sourc... | Industrials | $10.92 | 0.34 | — | $2.5B |
| 3 | NTRA | Natera, Inc. | Healthcare | $436.00 | 0.31 | — | $62.8B |
| 4 | ILMN | Illumina, Inc. | Healthcare | $290.06 | 0.28 | — | $43.8B |
| 5 | REPL | Replimune Group, Inc. | Healthcare | $17.39 | 0.23 | — | $1.6B |
| 6 | TEM | Tempus AI, Inc. | Healthcare | $77.84 | 0.21 | — | $13.8B |
| 7 | TWST | Twist Bioscience Corpo... | Healthcare | $173.45 | 0.20 | — | $11.4B |
| 8 | SDGR | Schrödinger, Inc. | Healthcare | $29.99 | 0.19 | — | $2.2B |
| 9 | CTS | CTS Corporation | Technology | $63.44 | 0.19 | — | $1.8B |
| 10 | GM | General Motors Company | Consumer Cyclical | $85.72 | 0.18 | — | $72.8B |
Recent Headlines
ILMN (Illumina, Inc.)
- Illumina (ILMN) Q3 Earnings Beat Estimates
- Illumina Q3 Earnings Call Highlights
- Illumina Q3 2026 Earnings Call Transcript
- Illumina Reports Financial Results for Third Quarter of Fiscal Year 2026
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Support the project by liking, sharing, or subscribing — it helps more readers discover these signals.